Vanda Pharmaceuticals And Novartis Settle License Dispute
December 23, 2014 at 08:08 AM EST
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced on Monday that it has agreed to settle a dispute over the rights to Fanapt with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.